A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that integrates the delivery of insulin with continuous glucose monitoring (CGM ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the Inflation Reduction Act that passed during the Biden administration.

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight.

HHS Secretary Robert F. Kennedy and FDA Commissioner Martin Makary announced a phase-out of all petroleum-based synthetic dyes in the nation’s food supply on Tuesday at a press conference.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a newer type of medication used to help people with diabetes manage ...

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...